Eric Kaldjian

4.3k total citations
51 papers, 3.3k citations indexed

About

Eric Kaldjian is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Eric Kaldjian has authored 51 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 21 papers in Cancer Research and 18 papers in Molecular Biology. Recurrent topics in Eric Kaldjian's work include Cancer Genomics and Diagnostics (17 papers), Cancer Cells and Metastasis (15 papers) and Immunotherapy and Immune Responses (6 papers). Eric Kaldjian is often cited by papers focused on Cancer Genomics and Diagnostics (17 papers), Cancer Cells and Metastasis (15 papers) and Immunotherapy and Immune Responses (6 papers). Eric Kaldjian collaborates with scholars based in United States, Canada and Poland. Eric Kaldjian's co-authors include Stephen Shaw, Arthur O. Anderson, John N. Weinstein, Judith S. Sebolt–Leopold, Oday Hamid, Jae K. Lee, Valeria Ossovskaya, Barry M. Sherman, Elaine S. Jaffe and Mary Varterasian and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Eric Kaldjian

49 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Kaldjian United States 23 1.4k 1.2k 725 531 475 51 3.3k
Trivadi S. Ganesan India 32 1.7k 1.2× 1.2k 1.1× 590 0.8× 529 1.0× 365 0.8× 166 3.8k
Loren Joseph United States 36 1.4k 1.0× 835 0.7× 657 0.9× 406 0.8× 402 0.8× 75 3.2k
Marc Mareel Belgium 27 1.7k 1.2× 1.4k 1.2× 761 1.0× 460 0.9× 574 1.2× 47 3.9k
Makoto Saegusa Japan 38 1.8k 1.3× 1.3k 1.1× 680 0.9× 460 0.9× 565 1.2× 163 3.8k
Bjørn Risberg Norway 41 1.8k 1.2× 1.4k 1.2× 877 1.2× 556 1.0× 761 1.6× 131 4.6k
Jessica Wang‐Rodriguez United States 34 2.0k 1.4× 959 0.8× 894 1.2× 284 0.5× 634 1.3× 96 3.9k
Reinhard von Wasielewski Germany 33 1.5k 1.1× 1.3k 1.1× 578 0.8× 677 1.3× 443 0.9× 102 3.9k
Kalle Alanen Finland 34 1.5k 1.0× 1.5k 1.3× 754 1.0× 377 0.7× 942 2.0× 98 3.8k
Denise C. Connolly United States 35 2.0k 1.4× 1.5k 1.3× 736 1.0× 501 0.9× 353 0.7× 97 4.5k
Ahmed Shabaik United States 24 2.1k 1.4× 1.1k 0.9× 627 0.9× 698 1.3× 620 1.3× 71 3.8k

Countries citing papers authored by Eric Kaldjian

Since Specialization
Citations

This map shows the geographic impact of Eric Kaldjian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Kaldjian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Kaldjian more than expected).

Fields of papers citing papers by Eric Kaldjian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Kaldjian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Kaldjian. The network helps show where Eric Kaldjian may publish in the future.

Co-authorship network of co-authors of Eric Kaldjian

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Kaldjian. A scholar is included among the top collaborators of Eric Kaldjian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Kaldjian. Eric Kaldjian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kennedy, Laura C., Jun Lü, Arturo B. Ramirez, et al.. (2022). Liquid Biopsy Assessment of Circulating Tumor Cell PD-L1 and IRF-1 Expression in Patients with Advanced Solid Tumors Receiving Immune Checkpoint Inhibitor. Targeted Oncology. 17(3). 329–341. 3 indexed citations
2.
Kaldjian, Eric, et al.. (2022). Beyond Circulating Tumor Cell Enumeration: Cell-Based Liquid Biopsy to Assess Protein Biomarkers and Cancer Genomics Using the RareCyte® Platform. Frontiers in Pharmacology. 13. 835727–835727. 8 indexed citations
3.
4.
Vossaert, Liesbeth, Qun Wang, Chunjing Qu, et al.. (2018). Reliable detection of subchromosomal deletions and duplications using cell‐based noninvasive prenatal testing. Prenatal Diagnosis. 38(13). 1069–1078. 31 indexed citations
5.
Stilwell, Jackie L., Paulina Varshavskaya, Joshua J. Nordberg, et al.. (2017). RareCyte® CTC Analysis Step 3: Using the CytePicker® Module for Individual Cell Retrieval and Subsequent Whole Genome Amplification of Circulating Tumor Cells for Genomic Analysis. Methods in molecular biology. 1634. 181–192. 5 indexed citations
6.
Ramirez, Arturo B., Lance U’Ren, Daniel Campton, et al.. (2017). RareCyte® CTC Analysis Step 1: AccuCyte® Sample Preparation for the Comprehensive Recovery of Nucleated Cells from Whole Blood. Methods in molecular biology. 1634. 163–172. 16 indexed citations
8.
Nickens, Kristen P., Ying Han, Gary F. Gerard, et al.. (2011). Acquisition of mitochondrial dysregulation and resistance to mitochondrial-mediated apoptosis after genotoxic insult in normal human fibroblasts: A possible model for early stage carcinogenesis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1823(2). 264–272. 6 indexed citations
10.
Goldknopf, Ira L., Essam A. Sheta, Stanley H. Appel, et al.. (2009). Abnormal serum concentrations of proteins in Parkinson’s disease. Biochemical and Biophysical Research Communications. 389(2). 321–327. 22 indexed citations
11.
Blower, Paul E., Joseph S. Verducci, Shili Lin, et al.. (2007). MicroRNA expression profiles for the NCI-60 cancer cell panel. Molecular Cancer Therapeutics. 6(5). 1483–1491. 194 indexed citations
12.
Ossovskaya, Valeria, et al.. (2007). PARP1 gene over-expression in primary human cancers: A potential marker for PARP inhibition. Molecular Cancer Therapeutics. 6. 1 indexed citations
13.
Ricciardi, Maria Rosaria, Teresa McQueen, David D. Chism, et al.. (2005). Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia. Leukemia. 19(9). 1543–1549. 97 indexed citations
14.
Man, Michael, et al.. (2004). The influence of tumor size and environment on gene expression in commonly used human tumor lines. BMC Cancer. 4(1). 35–35. 12 indexed citations
16.
Kaldjian, Lauris C., et al.. (1999). Insertion of Femoral-Vein Catheters for Practice by Medical House Officers during Cardiopulmonary Resuscitation. New England Journal of Medicine. 341(27). 2088–2091. 21 indexed citations
17.
Andriko, Jo‐Ann W., Eric Kaldjian, Maria Tsokos, Susan L. Abbondanzo, & Elaine S. Jaffe. (1998). Reticulum Cell Neoplasms of Lymph Nodes. The American Journal of Surgical Pathology. 22(9). 1048–1058. 90 indexed citations
18.
19.
Kaldjian, Eric & Lloyd M. Stoolman. (1995). Regulation of L-selectin mRNA in Jurkat cells. Opposing influences of calcium- and protein kinase C-dependent signaling pathways.. The Journal of Immunology. 154(9). 4351–4362. 22 indexed citations
20.
Kaldjian, Eric, Gwo-Hsiao Chen, & Kemp B. Cease. (1992). Enhancement of lymphocyte proliferation assays by use of serum-free medium. Journal of Immunological Methods. 147(2). 189–195. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026